BioArctic AB (publ) (LON:0RV2)

BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of GBP 2.03 billion. The enterprise value is 1.89 billion.

Market Cap	2.03B
Enterprise Value	1.89B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	30.72%
Owned by Institutions (%)	47.70%
Float	55.64M

Valuation Ratios

The trailing PE ratio is 25.78 and the forward PE ratio is 45.42.

PE Ratio	25.78
Forward PE	45.42
PS Ratio	13.45
PB Ratio	13.08
P/TBV Ratio	13.08
P/FCF Ratio	24.22
P/OCF Ratio	23.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.89, with an EV/FCF ratio of 22.47.

EV / Earnings	23.91
EV / Sales	12.27
EV / EBITDA	19.89
EV / EBIT	20.12
EV / FCF	22.47

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.02.

Current Ratio	4.18
Quick Ratio	3.14
Debt / Equity	0.02
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	36.78

Financial Efficiency

Return on equity (ROE) is 69.23% and return on invested capital (ROIC) is 48.85%.

Return on Equity (ROE)	69.23%
Return on Assets (ROA)	39.55%
Return on Invested Capital (ROIC)	48.85%
Return on Capital Employed (ROCE)	58.41%
Revenue Per Employee	1.27M
Profits Per Employee	663,249
Employee Count	107
Asset Turnover	1.04
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 13.65 million in taxes.

Income Tax	13.65M
Effective Tax Rate	14.75%

Stock Price Statistics

The stock price has increased by +96.13% in the last 52 weeks. The beta is -0.92, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.92
52-Week Price Change	+96.13%
50-Day Moving Average	288.53
200-Day Moving Average	227.28
Relative Strength Index (RSI)	56.83
Average Volume (20 Days)	16,872

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of GBP 151.29 million and earned 78.93 million in profits. Earnings per share was 0.89.

Revenue	151.29M
Gross Profit	146.87M
Operating Income	92.28M
Pretax Income	92.58M
Net Income	78.93M
EBITDA	n/a
EBIT	92.28M
Earnings Per Share (EPS)	0.89

Balance Sheet

The company has 148.58 million in cash and 3.68 million in debt, giving a net cash position of 144.91 million.

Cash & Cash Equivalents	148.58M
Total Debt	3.68M
Net Cash	144.91M
Net Cash Per Share	n/a
Equity (Book Value)	155.48M
Book Value Per Share	1.75
Working Capital	150.65M

Cash Flow

In the last 12 months, operating cash flow was 86.09 million and capital expenditures -2.10 million, giving a free cash flow of 83.98 million.

Operating Cash Flow	86.09M
Capital Expenditures	-2.10M
Free Cash Flow	83.98M
FCF Per Share	n/a

Margins

Gross margin is 97.08%, with operating and profit margins of 60.99% and 52.17%.

Gross Margin	97.08%
Operating Margin	60.99%
Pretax Margin	61.19%
Profit Margin	52.17%
EBITDA Margin	n/a
EBIT Margin	60.99%
FCF Margin	55.51%

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.71%
Shareholder Yield	-0.71%
Earnings Yield	3.88%
FCF Yield	4.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6